NEW YORK (Reuters) - CVS Health Corp (>> CVS Health) on Thursday said that a request for more information from U.S. antitrust regulators reviewing its proposed $69 billion acquisition of health insurer Aetna Inc (>> Aetna) does not impact its expectation that the deal will close in the second half of 2018.

The companies said on Feb. 1 that they had been contacted by the U.S. Department of Justice for additional information. The companies have a shareholder meeting scheduled for March 20 to vote on the transaction.

(Reporting by Caroline HumerEditing by Chizu Nomiyama)

Stocks treated in this article : Aetna, CVS Health